Beijing Balance Medical Technology Co Ltd (688198): Kapitalflussrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 67,41 Renminbi Yuan | 132,94 Renminbi Yuan | 67,35 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 137.748.133 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 620.150,252 | 501.879,122 | 370.638,328 | 295.166,72 | 251.817,559 | 181.917,903 | 146.033,297 | 110.648,032 | 92.347,144 | 78.459,946 |
Cashflow aus operativer Geschäftstätigkeit | 197.793,03 | 136.231,273 | 141.165,116 | 128.847,318 | 76.494,972 | 50.764,074 | 63.880,515 | 53.919,343 | 46.382,961 | 45.066,358 |
▸ Operative Cashflow Marge | 31,89% | 27,14% | 38,09% | 43,65% | 30,38% | 27,9% | 43,74% | 48,73% | 50,23% | 57,44% |
Investitionsausgaben (CapEx) | 136.196,464 | 163.255,477 | 128.631,058 | 104.833,827 | 72.223,604 | 7.694,526 | 2.017,517 | 2.184,484 | 13.096,916 | 13.540,091 |
Cashflow aus Investitionstätigkeit | - | - | - | -115.022,821 | -64.638,201 | -596.938,915 | -531,565 | - | - | - |
Cashflow aus Finanzierungstätigkeit | - | - | - | -38.311,38 | -9.286,234 | -22.741 | 509.511,4 | - | - | - |
Freier Cashflow | 61.596,566 | -27.024,203 | 12.534,058 | 24.013,491 | 4.271,368 | 43.069,548 | 61.862,998 | 51.734,859 | 33.286,045 | 31.526,267 |
▸ Freie Cashflow Marge | 9,93% | -5,38% | 3,38% | 8,14% | 1,7% | 23,68% | 42,36% | 46,76% | 36,04% | 40,18% |
Ausgeschüttete Dividenden | -110.837,76 | -109.263,392 | -67.836,738 | -48.219,154 | -19.201,958 | -19.200 | -19.200 | -25.000 | - | -14.618,847 |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | - | - | - | - | - | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.